Last reviewed · How we verify

NCT05013073: ASTHMAXcel

ASTHMAXcel Emergency Department Study

Terminated NA Last updated 21 September 2023
What this trial tests

NA trial testing ASTHMAXcel ED Application in Asthma in 160 participants. Terminated before completion.

Timeline
1 May 2021
Primary endpoint
7 February 2023
7 February 2023

Quick facts

Lead sponsorMontefiore Medical Center
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment160
Start date1 May 2021
Primary completion7 February 2023
Estimated completion7 February 2023
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Montefiore Medical Center

Who can join

Adults 18 to 100, any sex, with Asthma or Asthma Attack. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This protocol focuses on Phase 1 of a planned two-phase research project. Phase 1 aims to test and adapt a prototype ASTHMAXcelED application for the ED. Phase 2 will be an RCT to test the efficacy of a refined ASTHMAXcelED app after being modified based on the results of Phase 1.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other Montefiore Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05013073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing